Cargando…
Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
Autores principales: | Kozak, Kathryn E., Ouyang, Linda, Derkach, Andriy, Sherman, Alexandra, McCall, Susan J., Famulare, Christopher, Chervin, Jordan, Daley, Ryan J., Morjaria, Sejal, Mauro, Michael J., Rampal, Raajit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569492/ https://www.ncbi.nlm.nih.gov/pubmed/34741117 http://dx.doi.org/10.1038/s41375-021-01457-1 |
Ejemplares similares
-
Targeted therapies for myeloproliferative neoplasms
por: Li, Bing, et al.
Publicado: (2019) -
Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges
por: Ajufo, Helen O., et al.
Publicado: (2023) -
Philadelphia-negative chronic myeloproliferative neoplasms
por: Bittencourt, Rosane Isabel, et al.
Publicado: (2012) -
Molecular biology of Philadelphia-negative myeloproliferative neoplasms
por: Campregher, Paulo Vidal, et al.
Publicado: (2012) -
Inflammatory picture of Philadelphia-negative myeloproliferative neoplasms()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2018)